[fcb5af]: / literature / by_gene / NFKB2.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 34714908 10.1182/bloodadvances.2021005486 2022 Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways. NFKB2
2 36009586 10.3390/biomedicines10082038 2022 Genomic Aberrations Generate Fusion Gene FOXK2::TP63 and Activate NFKB1 in Cutaneous T-Cell Lymphoma. NFKB2
3 33184494 10.1038/s41375-020-01088-y 2021 A novel model of alternative NF-κB pathway activation in anaplastic large cell lymphoma. NFKB2
4 31586084 10.1038/s41598-019-50528-y 2020 Expression Of Intracellular Components of the NF-κB Alternative Pathway (NF-κB2, RelB, NIK and Bcl3) is Associated With Clinical Outcome of NSCLC Patients. NFKB2
5 32350066 10.1158/0008-5472.CAN-19-2247 2020 FBXW7 Triggers Degradation of KMT2D to Favor Growth of Diffuse Large B-cell Lymphoma Cells. NFKB2
6 29973688 10.1038/s41388-018-0363-4 2019 Alternative NF-κB signaling promotes colorectal tumorigenesis through transcriptionally upregulating Bcl-3. NFKB2
7 30401751 10.1182/bloodadvances.2018022962 2019 Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemia. NFKB2
8 30857150 10.3390/ijms20051182 2019 Temporal Splicing Switches in Elements of the TNF-Pathway Identified by Computational Analysis of Transcriptome Data for Human Cell Lines. NFKB2
9 29693141 10.3892/mmr.2018.8911 2018 Analysis of NFKB2‑mediated regulation of mechanisms underlying the development of Hodgkin's lymphoma. NFKB2
10 25912249 10.4274/tjh.2014.0190 2017 Deregulated Levels of the NF-κB1, NF-κB2, and Rel Genes in Ukrainian Patients with Leukemia and Lymphoma in the Post-Chernobyl Period. NFKB2
11 27039262 10.1016/j.jid.2016.03.024 2017 Identification of Gene Mutations and Fusion Genes in Patients with Sézary Syndrome. NFKB2
12 28368397 10.1038/onc.2017.90 2017 Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype. NFKB2
13 28689659 10.1016/j.molcel.2017.06.011 2017 Bcl3 Phosphorylation by Akt, Erk2, and IKK Is Required for Its Transcriptional Activity. NFKB2
14 26455434 10.1038/ncomms9428 2016 Transcriptional repression by the HDAC4-RelB-p52 complex regulates multiple myeloma survival and growth. NFKB2
15 26556860 10.18632/oncotarget.5715 2016 The Hsp90 inhibitor SNX-7081 is synergistic with fludarabine nucleoside via DNA damage and repair mechanisms in human, p53-negative chronic lymphocytic leukemia. NFKB2
16 25873174 10.1016/j.ccell.2015.03.006 2015 Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. NFKB2
17 25873381 10.1128/mBio.00441-15 2015 Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3. NFKB2
18 26112410 10.1074/jbc.M114.630061 2015 The Transitional Endoplasmic Reticulum ATPase p97 Regulates the Alternative Nuclear Factor NF-κB Signaling via Partial Degradation of the NF-κB Subunit p100. NFKB2
19 21787835 10.1016/j.mce.2011.07.021 2012 Inhibition of Bcl3 gene expression mediates the anti-proliferative action of estrogen in pituitary lactotrophs in primary culture. NFKB2
20 21871426 10.1016/j.ajpath.2011.07.003 2012 p52 Activation in monomorphic B-cell posttransplant lymphoproliferative disorder/diffuse large B-cell lymphoma without BAFF-R expression. NFKB2
21 22083306 10.1007/s10059-011-0177-5 2012 Nuclear factor-κB2 represses Sp1-mediated transcription at the CD99 promoter. NFKB2
22 22624040 10.1371/journal.pone.0037498 2012 A computational profiling of changes in gene expression and transcription factors induced by vFLIP K13 in primary effusion lymphoma. NFKB2
23 22642622 10.1186/1471-2407-12-203 2012 NF-κB2 mutation targets survival, proliferation and differentiation pathways in the pathogenesis of plasma cell tumors. NFKB2
24 21228035 10.3324/haematol.2010.030577 2011 Polymorphisms of nuclear factor-κB family genes are associated with development of multiple myeloma and treatment outcome in patients receiving bortezomib-based regimens. NFKB2
25 19773279 10.1136/oem.2008.044024 2010 Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity. NFKB2
26 20558726 10.1074/jbc.M110.112128 2010 BCL-3 degradation involves its polyubiquitination through a FBW7-independent pathway and its binding to the proteasome subunit PSMB1. NFKB2
27 20598117 10.1186/1471-2407-10-348 2010 Myc suppression of Nfkb2 accelerates lymphomagenesis. NFKB2
28 20800578 10.1016/j.bbrc.2010.08.084 2010 Bcl3-dependent stabilization of CtBP1 is crucial for the inhibition of apoptosis and tumor progression in breast cancer. NFKB2
29 19219072 10.1038/onc.2009.6 2009 Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-kappaB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes. NFKB2
30 19573080 10.1111/j.1365-2141.2009.07790.x 2009 Common genetic variants in candidate genes and risk of familial lymphoid malignancies. NFKB2
31 17573907 10.1111/j.1462-5822.2007.00950.x 2008 Alteration of NF-kappaB activity leads to mitochondrial apoptosis after infection with pathological prion protein. NFKB2
32 18025803 10.1159/000111116 2008 Expression of nuclear factor-kappaB family proteins in hepatocellular carcinomas. NFKB2
33 18367492 10.3324/haematol.12221 2008 Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia. NFKB2
34 18377428 10.1111/j.1349-7006.2008.00750.x 2008 Rearranged NF-kappa B2 gene in an adult T-cell leukemia cell line. NFKB2
35 17134739 10.1016/j.humpath.2006.08.023 2007 Composite splenic marginal zone lymphoma and mantle cell lymphoma arising from 2 independent B-cell clones. NFKB2
36 17356384 10.1097/01.jnen.0000248553.45456.96 2007 Transcriptional profiling of the nuclear factor-kappaB pathway identifies a subgroup of primary lymphoma of the central nervous system with low BCL10 expression. NFKB2
37 17476277 10.1038/sj.leu.2404723 2007 Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB (RelB/p52) in non-Hodgkin's lymphoma cells. NFKB2
38 16490595 10.1016/j.cancergencyto.2005.08.008 2006 Translocation (5;10)(q22;q24) in a case of acute lymphoblastic leukemia. NFKB2
39 16751281 10.1073/pnas.0507809103 2006 The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas. NFKB2
40 16940298 10.1074/jbc.M603194200 2006 Up-regulation of cyclin D1 by HBx is mediated by NF-kappaB2/BCL3 complex through kappaB site of cyclin D1 promoter. NFKB2
41 15384172 10.1002/gcc.20104 2005 A microarray model system identifies potential new target genes of the proto-oncogene HOX11. NFKB2
42 15782119 10.1038/sj.onc.1208564 2005 Aberrant NF-kappaB2/p52 expression in Hodgkin/Reed-Sternberg cells and CD30-transformed rat fibroblasts. NFKB2
43 16108830 10.1111/j.1349-7006.2005.00078.x 2005 Stimulation of CD30 in anaplastic large cell lymphoma leads to production of nuclear factor-kappaB p52, which is associated with hyperphosphorylated Bcl-3. NFKB2
44 14678988 2004 Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma. NFKB2
45 15469820 10.1016/j.molcel.2004.09.004 2004 GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity. NFKB2
46 12808109 10.1128/MCB.23.13.4713-4727.2003 2003 p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1. NFKB2
47 12835724 10.1038/sj.leu.2402982 2003 NF- kappa B2/p100 induces Bcl-2 expression. NFKB2
48 12894228 10.1038/sj.onc.1206761 2003 Regulation of NF-kappaB2/p100 processing by its nuclear shuttling. NFKB2
49 14576817 10.1038/sj.onc.1207120 2003 Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway. NFKB2
50 11707390 10.1093/emboj/20.22.6180 2002 Crystal structure of the ankyrin repeat domain of Bcl-3: a unique member of the IkappaB protein family. NFKB2
51 10713675 10.1038/sj.onc.1203432 2000 Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes. NFKB2
52 10830747 10.3109/10428190009087031 2000 Normal structure of NFKB2, C-REL and BCL-3 gene loci in lymphoproliferative and myeloproliferative disorders. NFKB2
53 9407099 10.1074/jbc.272.52.33132 1998 Diverse effects of BCL3 phosphorylation on its modulation of NF-kappaB p52 homodimer binding to DNA. NFKB2
54 9021684 10.3109/10428199609054800 1997 The involvement of the candidate proto-oncogene NFKB2/lyt-10 in lymphoid malignancies. NFKB2
55 9264393 10.1038/sj.leu.2400778 1997 Germline configuration of nfkb2, c-rel and bcl3 in childhood acute lymphoblastic leukemia (ALL). NFKB2
56 7579411 1995 Molecular analysis of cutaneous B- and T-cell lymphomas. NFKB2
57 7597296 10.1007/978-3-642-78771-3_19 1995 bcl-1, bcl-2, p53, c-myc, and lyt-10 analysis in cutaneous lymphomas. NFKB2
58 7949142 1994 Heterogeneous chromosomal aberrations generate 3' truncations of the NFKB2/lyt-10 gene in lymphoid malignancies. NFKB2
59 8036016 1994 Rearrangement and altered expression of the NFKB-2 gene in human cutaneous T-lymphoma cells. NFKB2
60 8108136 1994 Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10. NFKB2
61 8113688 10.1084/jem.179.3.961 1994 The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein. NFKB2
62 8208540 1994 Rearranged NFKB2 gene in the HUT78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional repressor functions. NFKB2
63 7692229 10.1128/mcb.13.10.6283-6289.1993 1993 Differential regulation of vascular cell adhesion molecule 1 gene expression by specific NF-kappa B subunits in endothelial and epithelial cells. NFKB2
64 8378093 1993 Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies. NFKB2
65 8453667 10.1016/0092-8674(93)90401-b 1993 The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers. NFKB2
66 1612589 10.1016/0888-7543(92)90244-m 1992 Related subunits of NF-kappa B map to two distinct loci associated with translocations in leukemia, NFKB1 and NFKB2. NFKB2
67 1760839 10.1016/0092-8674(91)90285-7 1992 B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50. NFKB2